Interpretation of ESPRIT in the FASTER trial

Lancet Neurol. 2008 Mar;7(3):198-9; author reply 199. doi: 10.1016/S1474-4422(08)70030-9.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspirin / therapeutic use
  • Clinical Trials as Topic*
  • Data Interpretation, Statistical*
  • Humans
  • Ischemic Attack, Transient / drug therapy
  • Secondary Prevention
  • Stroke / drug therapy
  • Stroke / epidemiology
  • Stroke / prevention & control*

Substances

  • Aspirin